The American Red Cross, renowned for its humanitarian services, operates on a substantial budget, with over $3.2 billion in revenue and just over $3 billion in expenses in 2022. While contributions constitute about a third of its revenue, the majority, over $1.8 billion, comes from “Biomedical services.” This involves the organization collecting blood from donors… Continue reading Here’s how the American Red Cross makes money from donated blood

A recent large-scale analysis of real-world data conducted by Truveta Research suggests that the diabetes drug Mounjaro, manufactured by Eli Lilly, is more effective for weight loss than the popular treatment Ozempic by Novo Nordisk in overweight or obese adults. Truveta Research, a firm specializing in compiling and analyzing patient data from healthcare systems, revealed… Continue reading Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says

Chinese authorities have expressed concerns as a rise in respiratory illnesses, including clusters of pneumonia among children, puts pressure on healthcare facilities in the northern part of the country. The World Health Organization (WHO) responded to reports of undiagnosed pneumonia in children’s hospitals, and while Chinese health authorities reported no changes in disease presentation, the… Continue reading China reports no ‘unusual or novel pathogens’ after WHO seeks data on respiratory illness outbreak

Sangamo Therapeutics Inc. has halted research on an experimental gene therapy for Fabry disease due to the “challenging economic environment” affecting the biotech industry. This decision is a consequence of the broader financial struggles faced by the biotech sector, with many companies grappling with reduced funding, rising interest rates, and uncertainties related to drug pricing… Continue reading A Biotech Slump Is Emptying Labs and Threatening Research on New Drugs

The threat of drug-resistant superbugs, known as antimicrobial resistance (AMR), is exacerbated by climate change, according to experts. AMR, often referred to as the “silent pandemic” by the World Health Organization, is a global health crisis with an estimated 1.3 million deaths annually due to resistant pathogens. The UN Environment Program’s report, “Bracing for Superbugs,”… Continue reading ‘The silent pandemic’: A hotter world makes it harder to stop the spread of deadly superbugs

The Biden administration has announced a new round of free at-home Covid tests for U.S. households in preparation for the upcoming holiday season, a time when indoor gatherings often lead to increased virus transmission. Starting immediately, Americans can request four free tests through COVIDtests.gov. Those who haven’t ordered any tests this fall can place two… Continue reading U.S. to offer another round of free at-home Covid tests starting Monday

Prison healthcare company Tehum Care Services, involved in a bankruptcy case related to medical malpractice lawsuits against its predecessor Corizon Health, has received court approval to proceed with a new mediator. The former bankruptcy judge, David Jones, resigned from the case due to a romantic relationship with an attorney involved in the negotiations, leading to… Continue reading Prison healthcare company restarts mediation after bankruptcy judge Jones quits

Belgium has implemented stricter rules governing the prescription of Novo Nordisk’s Ozempic and other diabetes medications in response to shortages caused by increased demand for weight loss purposes. The Federal Agency for Medicines and Health Products issued a legally binding directive stating that these drugs, including Novo’s Rybelsus and Victoza, as well as Eli Lilly’s… Continue reading Belgium limits Novo’s Ozempic to diabetes, obesity patients

FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX“), a nanotechnology company developing surface protection coatings to reduce the spread of pathogens, is pleased to provide the following letter to shareholders and investors from Dr. Carolyn Myers, the Company’s President and CEO. Dear FendX Shareholders, I am pleased to provide an… Continue reading FendX Provides Corporate Update

Novo Nordisk’s Wegovy has demonstrated significant cardiovascular benefits for individuals with obesity and heart disease in the Select study, a trial involving around 17,500 participants. This trial focused on individuals without diabetes, and the results showed that weekly injections of Wegovy reduced the overall risk of heart attack, stroke, and death from cardiovascular causes by… Continue reading Novo Nordisk’s weight loss drug Wegovy slashes risk of serious heart events

Pfizer is entering the weight loss drug market, aiming to rebound from diminishing demand for its Covid products and reverse a roughly 40% share price drop in 2023. The company’s experimental obesity pill, danuglipron, is under scrutiny, with upcoming phase two trial data anticipated by the end of the year. Pfizer’s foray into this market… Continue reading Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success

The article discusses the rising popularity of Prenuvo, a Silicon Valley-based company that offers full-body MRI scans to help identify various medical conditions, including cancer, multiple sclerosis, and brain aneurysms. The company, backed by investors like Kim Kardashian, Google ex-Chairman Eric Schmidt, and others, raised $70 million in a funding round last year. Patients, including… Continue reading Patients are lining up for $2,500 full-body MRI scans that can detect cancer early